CEPTUR THERAPEUTICS
Ceptur is developing unique and differentiated genetic medicines for patients with unaddressed diseases. The Company’s wholly owned and proprietary U1 Adaptor technology promotes non-genotoxic and long-lasting silencing of disease-causing genes in difficult to target tissues (i.e., outside of the liver and CNS).
CEPTUR THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical Therapeutics
Founded:
2008-01-01
Address:
Hillsborough, New Jersey, United States
Country:
United States
Website Url:
http://www.Cepturtx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
81.2 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS GoDaddy DNS AWS Global Accelerator WPForms
Current Advisors List
Current Employees Featured
Founder
Investors List
Bristol Myers Squibb
Bristol Myers Squibb investment in Series A - Ceptur Therapeutics
Qiming Venture Partners
Qiming Venture Partners investment in Series A - Ceptur Therapeutics
Affinity Asset Advisors
Affinity Asset Advisors investment in Series A - Ceptur Therapeutics
Boxer Capital
Boxer Capital investment in Series A - Ceptur Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Series A - Ceptur Therapeutics
Janus Henderson Investors
Janus Henderson Investors investment in Series A - Ceptur Therapeutics
venBio Partners
venBio Partners investment in Series A - Ceptur Therapeutics
LifeSci Venture Partners
LifeSci Venture Partners investment in Series A - Ceptur Therapeutics
Affinity Asset Advisors
Affinity Asset Advisors investment in Venture Round - Ceptur Therapeutics
Official Site Inspections
http://www.Cepturtx.com
- Host name: 172.67.207.39
- IP address: 172.67.207.39
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ceptur Therapeutics"
Ceptur Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Ceptur is developing unique and differentiated genetic medicines for patients with unaddressed diseases. The Company’s wholly owned and proprietary U1 Adaptor technology promotes …See details»
Ceptur Therapeutics Company Profile 2024: Valuation, …
Ceptur Therapeutics General Information Description. Developer of U1 adaptor technology designed to facilitate the creation of treatment. The company's technology overcomes the limitations of gene silencing technologies and …See details»
Ceptur Therapeutics Company Profile | Management and
Www.cepturtx.com Ceptur Therapeutics Profile and History Headquartered in Hillsborough New Jersey, Ceptur Therapeutics is a pre-clinical stage biotechnology company focused on …See details»
Ceptur Therapeutics - Overview, News & Similar companies
Mar 14, 2022 www.cepturtx.com. Revenue <$5 Million. Industry Business Services General Business Services . Recent News & Media. Ceptur Appoints Romesh Subramanian to Its …See details»
Ceptur Therapeutics Launches with $75M Series A …
Jan 19, 2022 He is further a member of the European Molecular Biology Organization (EMBO) and helped to make The EMBO Journal a highly successful international publication, acting as Executive Editor from 1990 ...See details»
Ceptur Therapeutics - Company Profile & Staff Directory
Ceptur is developing unique and differentiated genetic medicines for patients with unaddressed diseases. The Company’s wholly owned and proprietary U1 Adaptor technology promotes non …See details»
CEPTUR THERAPEUTICS, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CEPTUR THERAPEUTICS, INC. of Hillsborough, NJ. Get the latest business insights from Dun & …See details»
Series A - Ceptur Therapeutics - 2022-01-19 - Crunchbase
Jan 19, 2022 Organization Name . Ceptur Therapeutics . Announced Date Jan 19, 2022; Closed On Date Feb 14, 2022; Funding Type Series A; Funding Stage Early Stage Venture; Money …See details»
Ceptur Therapeutics - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
A new RNA-based drug startup launches with Rutgers …
Jan 19, 2022 A Philadelphia-based biotech startup has raised an early round of cash to fund the development of RNA-based drugs that leverage a novel scientific discovery to shut down disease-causing genes.See details»
Ceptur Appoints Romesh Subramanian to Its Board of …
Mar 21, 2022 Ceptur Therapeutics, Inc. (“Ceptur”), a biotechnology company focused on the development of targeted oligonucleotides for gene silencing and RNA editiSee details»
cepturtx.com
Sep 7, 2021 cepturtx.com ... TaglineSee details»
Bristol Myers, VCs launch new RNA therapeutics biotech ... - Fierce …
Jan 19, 2022 Since Ceptur's oligos don't require an enzyme as part of the drug's effect on the body, there could be potential to avoid the two-step delivery needed by gene editing …See details»
Ceptur Therapeutics Launches with $75M Series A Financing to …
Jan 20, 2022 Dr. Mattaj was previously awarded the prestigious Louis-Jeantet Prize for Medicine in 2001. He is further a member of the European Molecular Biology Organization (EMBO) and …See details»
Ceptur Therapeutics Launches with $75M Series A Financing to
Jan 19, 2022 He is further a member of the European Molecular Biology Organization (EMBO) ... Keith Dewedoff, (215)-330-8399, [email protected]. Source: Ceptur Therapeutics, Inc. …See details»
Ceptur Therapeutics Launches with $75M Series A Financing to …
Jan 19, 2022 PHILADELPHIA--(BUSINESS WIRE)-- Ceptur Therapeutics, Inc. (“Ceptur”), a biotechnology company focused on developing targeted oligonucleotide therapeutics based on …See details»
@CepturTx | X
The latest posts from @CepturTxSee details»
Ceptur Therapeutics Launches with $75M Series A Financing to …
Jan 19, 2022 Financing co-led by venBio Partners & Qiming Venture Partners USA with participation from strong syndicate of new and existing investors Pioneering new wave of …See details»
Ceptur Therapeutics Launches with $75M Series A Financing to …
Jan 19, 2022 4dd8868ea336.C57VY8eNiJPDimV8aDMMUg6E32Bs_GhqHeIUggvRhHU.OvKlEoT0vf617j0ZAWxkZWXC5lUeqCcZLK1iwEGr90d8po0ZpMfO8vHcBg …See details»
Ceptur Therapeutics Launches with $75M Series A Financing to …
PHILADELPHIA–(BUSINESS WIRE)–Ceptur Therapeutics, Inc. (“Ceptur”), a biotechnology company focused on developing targeted oligonucleotide therapeutics based on U1 Adaptor …See details»